Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Kura Oncology, Inc.

Clinical trials sponsored by Kura Oncology, Inc., explained in plain language.

Kura Oncology, Inc. KURA NASDAQ

Clinical-stage biopharmaceutical company focused on cancer treatments.

Trade on eToro (ad)

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Trials to join now! 7 Not yet finished but already full! 1 Completed 1

New hope for tough leukemia: experimental drug targets genetic flaw

Disease control Ongoing

This study tests a new drug called ziftomenib (KO-539) in people with acute myeloid leukemia (AML) that has come back or not responded to treatment. The drug targets a specific genetic change (MLL rearrangement or NPM1 mutation) found in some patients. The goal is to find the saf…

Phase: PHASE1, PHASE2 • Sponsor: Kura Oncology, Inc. • Aim: Disease control

Last updated Jun 27, 2026 12:32 UTC